143 related articles for article (PubMed ID: 28518105)
1. Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT.
Hoffmann SHL; Maurer A; Reck DI; Reischl G; Pichler BJ; Kneilling M; Griessinger CM
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28518105
[TBL] [Abstract][Full Text] [Related]
2. 64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.
Griessinger CM; Maurer A; Kesenheimer C; Kehlbach R; Reischl G; Ehrlichmann W; Bukala D; Harant M; Cay F; Brück J; Nordin R; Kohlhofer U; Rammensee HG; Quintanilla-Martinez L; Schaller M; Röcken M; Pichler BJ; Kneilling M
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1161-6. PubMed ID: 25587131
[TBL] [Abstract][Full Text] [Related]
3. In vivo tracking of Th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue.
Griessinger CM; Kehlbach R; Bukala D; Wiehr S; Bantleon R; Cay F; Schmid A; Braumüller H; Fehrenbacher B; Schaller M; Eichner M; Sutcliffe JL; Ehrlichmann W; Eibl O; Reischl G; Cherry SR; Röcken M; Pichler BJ; Kneilling M
J Nucl Med; 2014 Feb; 55(2):301-7. PubMed ID: 24434289
[TBL] [Abstract][Full Text] [Related]
4. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
[TBL] [Abstract][Full Text] [Related]
5. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.
Zhang Y; Hong H; Engle JW; Bean J; Yang Y; Leigh BR; Barnhart TE; Cai W
PLoS One; 2011; 6(12):e28005. PubMed ID: 22174762
[TBL] [Abstract][Full Text] [Related]
7. TE1PA as Innovating Chelator for
Navarro AS; Le Bihan T; Le Saëc P; Bris NL; Bailly C; Saï-Maurel C; Bourgeois M; Chérel M; Tripier R; Faivre-Chauvet A
Bioconjug Chem; 2019 Sep; 30(9):2393-2403. PubMed ID: 31386357
[TBL] [Abstract][Full Text] [Related]
8. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
[TBL] [Abstract][Full Text] [Related]
9.
Kruziki MA; Case BA; Chan JY; Zudock EJ; Woldring DR; Yee D; Hackel BJ
Mol Pharm; 2016 Nov; 13(11):3747-3755. PubMed ID: 27696863
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.
Cai H; Li Z; Huang CW; Shahinian AH; Wang H; Park R; Conti PS
Bioconjug Chem; 2010 Aug; 21(8):1417-24. PubMed ID: 20666401
[TBL] [Abstract][Full Text] [Related]
11. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
[TBL] [Abstract][Full Text] [Related]
12. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using
Cao Q; Huang Q; Mohan C; Li C
J Nucl Med; 2019 Sep; 60(9):1317-1324. PubMed ID: 30796172
[TBL] [Abstract][Full Text] [Related]
13. ImmunoPET, [
Srideshikan SM; Brooks J; Zuro D; Kumar B; Sanchez J; Echavarria Parra L; Orellana M; Vishwasrao P; Nair I; Chea J; Poku K; Bowles N; Miller A; Ebner T; Molnar J; Rosenthal J; Vallera DA; Wong JYC; Stein AS; Colcher D; Shively JE; Yazaki PJ; Hui SK
Clin Cancer Res; 2019 Dec; 25(24):7463-7474. PubMed ID: 31548348
[TBL] [Abstract][Full Text] [Related]
14. Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
Song IH; Lee TS; Park YS; Lee JS; Lee BC; Moon BS; An GI; Lee HW; Kim KI; Lee YJ; Kang JH; Lim SM
J Nucl Med; 2016 Jul; 57(7):1105-11. PubMed ID: 26917708
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography.
Adonai N; Adonai N; Nguyen KN; Walsh J; Iyer M; Toyokuni T; Phelps ME; McCarthy T; McCarthy DW; Gambhir SS
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3030-5. PubMed ID: 11867752
[TBL] [Abstract][Full Text] [Related]
16. Cu
Han J; Wang X; Yu M
Bioorg Med Chem Lett; 2016 Nov; 26(22):5594-5596. PubMed ID: 27780640
[TBL] [Abstract][Full Text] [Related]
17. 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma.
Vavere AL; Butch ER; Dearling JL; Packard AB; Navid F; Shulkin BL; Barfield RC; Snyder SE
J Nucl Med; 2012 Nov; 53(11):1772-8. PubMed ID: 23064212
[TBL] [Abstract][Full Text] [Related]
18. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y
Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468
[TBL] [Abstract][Full Text] [Related]
19. Comparison of bifunctional chelates for (64)Cu antibody imaging.
Ferreira CL; Yapp DT; Crisp S; Sutherland BW; Ng SS; Gleave M; Bensimon C; Jurek P; Kiefer GE
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2117-26. PubMed ID: 20552190
[TBL] [Abstract][Full Text] [Related]
20. Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion.
Persson M; Madsen J; Østergaard S; Jensen MM; Jørgensen JT; Juhl K; Lehmann C; Ploug M; Kjaer A
J Nucl Med; 2012 Jan; 53(1):138-45. PubMed ID: 22213823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
